Inclusion criteria:
Patients aged 18 to 60 years
They signed informed consent forms and volunteered to participate in the experiments
They have had back pain for more than 3 months On examination
they have local sensitivity in the back, buttocks and legs, and shooting pain, and they have a Straight Leg Rising (SLR) test or a Slump test
MRI of the lumbar disc herniation was seen
Have the mental ability to answer questionnaire questions
Exclusion criteria:
Acute trauma or fracture of the lumbar spine or dysplasia of the spinal structure (spondylolysis)
Congenital anomaly, abdominal aneurysm 3. Lumbar spine surgery Uncontrolled or severe metabolic disorders or cardiovascular, hepatic and renal disorders
Lumbar spine surgery
Uncontrolled or severe metabolic disorders or cardiovascular, hepatic and renal disorders
Inflammatory pain
Severe or progressive neurological disorders or lumbar instability
Physiotherapy treatments on the back in the last 3 months
History of lumbar injection in the last 4 weeks
Severe osteopenia
Systemic rheumatic disease (rheumatoid arthritis and fibromyalgia)
Spinal cancers and patients with spinal tuberculosis
Danger symptoms include nocturnal pain, recent involuntary weight loss, and symptoms of Cauda equina syndrome
Spondylolisthesis
Hypersensitivity to piroxicam and methocarbamol
Patients who have undergone lumbar spine fusion or have indication for surgery
Pregnant patients
Patients who have had a tattoo or melanocytic moles in or near the treatment areas
Patients with lupus or any other autoimmune disease, thrombophlebitis or anemia, and skin allergies
Not participating in treatment sessions for more than 2 sessions
Dissatisfaction with participating in the study at any stage of the study
No referral for follow-up 4 weeks later and no phone response 3 months after starting treatment
Emergence of severe medical diseases during the study that affect the individual's referral and follow-up